The fish oil market is growing due to rising consumer awareness of its health benefits, including heart, brain, and joint support. Demand is driven b ...

Common nutrition "myths" can be a waste of our efforts at best, and potentially dangerous at worst, which is why it's so ...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...